Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2018-June 2019.

Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Quddus A, Sutter R, Vertefeuille JF, Wenger J, Wassilak SGF, Pallansch MA, Burns CC.

MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1024-1028. doi: 10.15585/mmwr.mm6845a4.

2.

Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure.

Jallow S, Wilmshurst JM, Howard W, Copelyn J, Seakamela L, Chan KW, Sebunya R, Sibiya R, Du Plessis H, Jacobs C, Berkowitz N, Blumberg L, McCarthy K, Maseti E, Kamupira M, Dlamini N, Gumede N, Diop OM, Lau YL, Moonsamy S, Eley B, Suchard M.

Clin Infect Dis. 2020 Jan 1;70(1):132-135. doi: 10.1093/cid/ciz361.

3.

Detection and characterization of polioviruses originating from urban sewage in Yaounde and Douala, Cameroon 2016-2017.

Njile DK, Sadeuh-Mba SA, Endegue-Zanga MC, Mengouo MN, Djoumetio MD, Pouth FBB, Diop OM, Njouom R.

BMC Res Notes. 2019 May 2;12(1):248. doi: 10.1186/s13104-019-4280-6.

4.

Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2017-2018.

Patel JC, Diop OM, Gardner T, Chavan S, Jorba J, Wassilak SGF, Ahmed J, Snider CJ.

MMWR Morb Mortal Wkly Rep. 2019 Apr 5;68(13):312-318. doi: 10.15585/mmwr.mm6813a4.

5.

Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial.

Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, Widdowson MA, Neuzil KM, Victor JC.

Clin Infect Dis. 2019 Oct 30;69(10):1780-1788. doi: 10.1093/cid/ciz066.

6.

Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis.

Duintjer Tebbens RJ, Diop OM, Pallansch MA, Oberste MS, Thompson KM.

BMJ Open. 2019 Jan 21;9(1):e023290. doi: 10.1136/bmjopen-2018-023290.

7.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018.

Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Sutter RW, Wassilak SGF, Burns CC.

MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1189-1194. doi: 10.15585/mmwr.mm6742a5.

8.

Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.

Blake IM, Pons-Salort M, Molodecky NA, Diop OM, Chenoweth P, Bandyopadhyay AS, Zaffran M, Sutter RW, Grassly NC.

N Engl J Med. 2018 Aug 30;379(9):834-845. doi: 10.1056/NEJMoa1716677.

9.

Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study.

O'Reilly KM, Verity R, Durry E, Asghar H, Sharif S, Zaidi SZ, Wadood MZM, Diop OM, Okayasu H, Safdar RM, Grassly NC.

BMC Infect Dis. 2018 Apr 13;18(1):176. doi: 10.1186/s12879-018-3070-4.

10.

Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2016-2017.

Gardner TJ, Diop OM, Jorba J, Chavan S, Ahmed J, Anand A.

MMWR Morb Mortal Wkly Rep. 2018 Apr 13;67(14):418-423. doi: 10.15585/mmwr.mm6714a3.

11.

Role of monkeys in the sylvatic cycle of chikungunya virus in Senegal.

Althouse BM, Guerbois M, Cummings DAT, Diop OM, Faye O, Faye A, Diallo D, Sadio BD, Sow A, Faye O, Sall AA, Diallo M, Benefit B, Simons E, Watts DM, Weaver SC, Hanley KA.

Nat Commun. 2018 Mar 13;9(1):1046. doi: 10.1038/s41467-018-03332-7.

12.

Chikungunya Outbreak in Kedougou, Southeastern Senegal in 2009-2010.

Sow A, Faye O, Diallo M, Diallo D, Chen R, Faye O, Diagne CT, Guerbois M, Weidmann M, Ndiaye Y, Senghor CS, Faye A, Diop OM, Sadio B, Ndiaye O, Watts D, Hanley KA, Dia AT, Malvy D, Weaver SC, Sall AA.

Open Forum Infect Dis. 2017 Dec 2;5(1):ofx259. doi: 10.1093/ofid/ofx259. eCollection 2018 Jan.

13.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.

Jorba J, Diop OM, Iber J, Henderson E, Sutter RW, Wassilak SGF, Burns CC.

MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1185-1191. doi: 10.15585/mmwr.mm6643a6.

14.

The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks.

Diop OM, Kew OM, de Gourville EM, Pallansch MA.

J Infect Dis. 2017 Jul 1;216(suppl_1):S299-S307. doi: 10.1093/infdis/jix092.

15.

Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 - Worldwide, 2016-2017.

Diop OM, Asghar H, Gavrilin E, Moeletsi NG, Benito GR, Paladin F, Pattamadilok S, Zhang Y, Goel A, Quddus A.

MMWR Morb Mortal Wkly Rep. 2017 May 26;66(20):538-542. doi: 10.15585/mmwr.mm6620a4.

16.

Surveillance Systems to Track Progress Toward Polio Eradication - Worldwide, 2015-2016.

Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SG.

MMWR Morb Mortal Wkly Rep. 2017 Apr 7;66(13):359-365. doi: 10.15585/mmwr.mm6613a3.

17.

Satellite imagery technology in public health: analysis of site catchment areas for assessment of poliovirus circulation in Nigeria and Niger.

Takane M, Yabe S, Tateshita Y, Kobayashi Y, Hino A, Isono K, Okayasu H, Diop OM, Tadono T.

Geospat Health. 2016 Nov 21;11(3):462. doi: 10.4081/gh.2016.462.

18.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2015-May 2016.

Jorba J, Diop OM, Iber J, Sutter RW, Wassilak SG, Burns CC.

MMWR Morb Mortal Wkly Rep. 2016 Aug 5;65(30):763-9. doi: 10.15585/mmwr.mm6530a3.

19.

Enteroviruses and Rhinoviruses: Molecular Epidemiology of the Most Influenza-Like Illness Associated Viruses in Senegal.

Fall A, Dia N, Kébé O, Sarr FD, Kiori DE, Cissé el HA, Sy S, Goudiaby D, Richard V, Diop OM, Niang MN.

Am J Trop Med Hyg. 2016 Aug 3;95(2):339-47. doi: 10.4269/ajtmh.15-0799. Epub 2016 May 31.

20.

Surveillance Systems to Track Progress Toward Polio Eradication--Worldwide, 2014-2015.

Snider CJ, Diop OM, Burns CC, Tangermann RH, Wassilak SG.

MMWR Morb Mortal Wkly Rep. 2016 Apr 8;65(13):346-51. doi: 10.15585/mmwr.mm6513a3.

21.

Enterovirus A71 Genogroups C and E in Children with Acute Flaccid Paralysis, West Africa.

Fernandez-Garcia MD, Kebe O, Fall AD, Dia H, Diop OM, Delpeyroux F, Ndiaye K.

Emerg Infect Dis. 2016 Apr;22(4):753-5. doi: 10.3201/eid2204.151588. No abstract available.

22.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.

Diop OM, Burns CC, Sutter RW, Wassilak SG, Kew OM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):640-6.

23.

Epidemiology and genetic characterization of measles strains in Senegal, 2004-2013.

Dia N, Fall A, Ka R, Fall A, Kiori DE, Goudiaby DG, Fall AD, Faye el HA, Dosseh A, Ndiaye K, Diop OM, Niang MN.

PLoS One. 2015 May 22;10(5):e0121704. doi: 10.1371/journal.pone.0121704. eCollection 2015.

24.

Progress toward polio eradication - worldwide, 2014-2015.

Hagan JE, Wassilak SG, Craig AS, Tangermann RH, Diop OM, Burns CC, Quddus A; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 May 22;64(19):527-31.

25.

Tracking progress toward polio eradication - worldwide, 2013-2014.

Porter KA, Diop OM, Burns CC, Tangermann RH, Wassilak SG.

MMWR Morb Mortal Wkly Rep. 2015 Apr 24;64(15):415-20.

26.

Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?

Michel R, Berger F, Ravelonarivo J, Dussart P, Dia M, Nacher M, Rogier S, Moua D, Sarr FD, Diop OM, Sall AA, Baril L.

Vaccine. 2015 May 11;33(20):2301-6. doi: 10.1016/j.vaccine.2015.03.069. Epub 2015 Apr 2.

PMID:
25843268
27.

Possible eradication of wild poliovirus type 3--worldwide, 2012.

Kew OM, Cochi SL, Jafari HS, Wassilak SG, Mast EE, Diop OM, Tangermann RH, Armstrong GL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 14;63(45):1031-3.

28.

Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.

Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S5-15. doi: 10.1093/infdis/jiu456. Review.

29.

Environmental surveillance for polioviruses in the Global Polio Eradication Initiative.

Asghar H, Diop OM, Weldegebriel G, Malik F, Shetty S, El Bassioni L, Akande AO, Al Maamoun E, Zaidi S, Adeniji AJ, Burns CC, Deshpande J, Oberste MS, Lowther SA.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S294-303. doi: 10.1093/infdis/jiu384. Review.

PMID:
25316848
30.

Vaccine-derived polioviruses.

Burns CC, Diop OM, Sutter RW, Kew OM.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S283-93. doi: 10.1093/infdis/jiu295. Review.

PMID:
25316847
31.

Progress toward polio eradication--Worldwide, 2013-2014.

Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, Jafari H; EIS officer, CDC.

MMWR Morb Mortal Wkly Rep. 2014 May 30;63(21):468-72.

32.

Surveillance systems to track progress toward global polio eradication - worldwide, 2012-2013.

Levitt A, Diop OM, Tangermann RH, Paladin F, Kamgang JB, Burns CC, Chenoweth PJ, Goel A, Wassilak SG; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):356-61.

33.

Respiratory viruses associated with patients older than 50 years presenting with ILI in Senegal, 2009 to 2011.

Dia N, Richard V, Kiori D, Cisse el HA, Sarr FD, Faye A, Goudiaby DG, Diop OM, Niang MN.

BMC Infect Dis. 2014 Apr 8;14:189. doi: 10.1186/1471-2334-14-189.

34.

Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.

Diop OM, Burns CC, Wassilak SG, Kew OM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):242-8.

35.

Multiyear persistence of 2 pandemic A/H1N1 influenza virus lineages in West Africa.

Nelson MI, Njouom R, Viboud C, Niang MN, Kadjo H, Ampofo W, Adebayo A, Tarnagda Z, Miller MA, Holmes EC, Diop OM.

J Infect Dis. 2014 Jul 1;210(1):121-5. Epub 2014 Jan 19.

36.

Environmental surveillance of poliovirus and non-polio enterovirus in urban sewage in Dakar, Senegal (2007-2013).

Ndiaye AK, Diop PA, Diop OM.

Pan Afr Med J. 2014 Nov 4;19:243. doi: 10.11604/pamj.2014.19.243.3538. eCollection 2014.

37.

A subregional analysis of epidemiologic and genetic characteristics of influenza A(H1N1)pdm09 in Africa: Senegal, Cape Verde, Mauritania, and Guinea, 2009-2010.

Dia N, Ndiaye MN, Monteiro Mde L, Koivogui L, Bara MO, Diop OM.

Am J Trop Med Hyg. 2013 May;88(5):946-53. doi: 10.4269/ajtmh.12-0401. Epub 2013 Mar 18.

38.

Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Duintjer Tebbens RJ, Pallansch MA, Kim JH, Burns CC, Kew OM, Oberste MS, Diop OM, Wassilak SG, Cochi SL, Thompson KM.

Risk Anal. 2013 Apr;33(4):680-702. doi: 10.1111/risa.12022. Epub 2013 Mar 7.

PMID:
23470192
39.

Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal.

Dia N, Niang MN, Diadhiou SA, Goudiaby DG, Faye A, Kiori D, Bâ M, Michel R, Diop OM.

BMC Infect Dis. 2013 Feb 27;13:106. doi: 10.1186/1471-2334-13-106.

40.

Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network.

Heraud JM, Njouom R, Rousset D, Kadjo H, Caro V, Ndiaye MN, Victoir K, Collard JM, Orelle A, Yekwa EL, Ekaza E, Razanajatovo NH, Adamou L, Biscornet L, Enouf V, van der Werf S, Diop OM.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S5-13. doi: 10.1093/infdis/jis541.

PMID:
23169972
41.

Sentinel surveillance for influenza in Senegal, 1996-2009.

Niang MN, Dosseh A, Ndiaye K, Sagna M, Gregory V, Goudiaby D, Hay A, Diop OM.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S129-35. doi: 10.1093/infdis/jis576.

PMID:
23169958
42.

Delayed 2009 pandemic influenza A virus subtype H1N1 circulation in West Africa, May 2009-April 2010.

Nzussouo NT, Michalove J, Diop OM, Njouom R, Monteiro Mde L, Adje HK, Manoncourt S, Amankwa J, Koivogui L, Sow S, Elkory MB, Collard JM, Dalhatu I, Niang MN, Lafond K, Moniz F, Coulibaly D, Kronman KC, Oyofo BA, Ampofo W, Tamboura B, Bara AO, Jusot JF, Ekanem E, Sarr FD, Hwang I, Cornelius C, Coker B, Lindstrom S, Davis R, Dueger E, Moen A, Widdowson MA.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S101-7. doi: 10.1093/infdis/jis572. Erratum in: J Infect Dis. 2013 Mar 15;207(6):1026.

PMID:
23169954
43.

Afriflu--international conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, Morocco.

Steffen C, Diop OM, Gessner BD, Hacen MM, Hassar M, Katz MA, Miller MA, Paget WJ, Schoub BD, Vernet G, Ndumbe PM.

Vaccine. 2011 Jan 10;29(3):363-9. doi: 10.1016/j.vaccine.2010.11.029. Epub 2010 Nov 25.

PMID:
21111779
44.

Viral etiology of respiratory infections in children under 5 years old living in tropical rural areas of Senegal: The EVIRA project.

Niang MN, Diop OM, Sarr FD, Goudiaby D, Malou-Sompy H, Ndiaye K, Vabret A, Baril L.

J Med Virol. 2010 May;82(5):866-72. doi: 10.1002/jmv.21665.

PMID:
20336732
45.

Environmental risk factors of West Nile virus infection of horses in the Senegal River basin.

Chevalier V, Dupressoir A, Tran A, Diop OM, Gottland C, Diallo M, Etter E, Ndiaye M, Grosbois V, Dia M, Gaidet N, Sall AA, Soti V, Niang M.

Epidemiol Infect. 2010 Nov;138(11):1601-9. doi: 10.1017/S095026881000035X. Epub 2010 Feb 23.

PMID:
20175940
46.

Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys.

Lozano Reina JM, Favre D, Kasakow Z, Mayau V, Nugeyre MT, Ka T, Faye A, Miller CJ, Scott-Algara D, McCune JM, Barré-Sinoussi F, Diop OM, Müller-Trutwin MC.

J Virol. 2009 Mar;83(6):2770-7. doi: 10.1128/JVI.01841-08. Epub 2008 Dec 24.

47.

Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.

Diop OM, Ploquin MJ, Mortara L, Faye A, Jacquelin B, Kunkel D, Lebon P, Butor C, Hosmalin A, Barré-Sinoussi F, Müller-Trutwin MC.

J Virol. 2008 Jun;82(11):5145-52. doi: 10.1128/JVI.02433-07. Epub 2008 Apr 2.

48.

Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003.

Faye O, Diallo M, Diop D, Bezeid OE, Bâ H, Niang M, Dia I, Mohamed SA, Ndiaye K, Diallo D, Ly PO, Diallo B, Nabeth P, Simon F, Lô B, Diop OM.

Emerg Infect Dis. 2007 Jul;13(7):1016-23. doi: 10.3201/eid1307.061487.

49.

Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity.

Baena A, Mootnick AR, Falvo JV, Tsytskova AV, Ligeiro F, Diop OM, Brieva C, Gagneux P, O'Brien SJ, Ryder OA, Goldfeld AE.

PLoS One. 2007 Jul 18;2(7):e621.

50.

Long oligonucleotide microarrays for African green monkey gene expression profile analysis.

Jacquelin B, Mayau V, Brysbaert G, Regnault B, Diop OM, Arenzana-Seisdedos F, Rogge L, Coppée JY, Barré-Sinoussi F, Benecke A, Müller-Trutwin MC.

FASEB J. 2007 Oct;21(12):3262-71. Epub 2007 May 16.

PMID:
17507667

Supplemental Content

Support Center